Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting.

Phase 3

• Conditions: COVID-19; Infection - Other infectious diseases

• Registration Number: ACTRN12620000566932
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-14
• Study Completion: 2024-03-19
• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 195

Inclusion Criteria

1.Adult, aged greater than or equal to 18 years.
2.PCR or RAT-confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection.
3.Intention for community-based management.
4.Eligibility to at least one recruiting domain.
5.Participant & treating clinician are willing and able to comply with all study requirements, including treatment, timing and/or nature of required assessments, and.
6.Documented informed consent

Exclusion Criteria

1. Currently pregnant or breast-feeding
2. Any medical condition which, in the opinion of the Investigator, may affect the participant’s safety or study participation and conduct

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is the time to first recovery within 28 days of randomisation, defined as the number of days until the participant first reports an absence of all symptoms within 28 days after the date of randomisation. [ 28 days]